Inhalation Anesthesia Market Size By Product (Sevoflurane, Desflurane, Isoflurane), By Application (Induction, Maintenance), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jul 2019  |  Report ID: GMI704  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 170   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Inhalation Anesthesia Market size was valued at USD 1.3 billion in 2018 and is expected to witness 5.4% CAGR from 2019 to 2025. In addition, the number of 250 ml bottles sold is set to exceed 15,500 units by 2025.

Inhalation Anesthesia Market

Get more details on this report - Request Free Sample PDF

Surge in number of emergency and trauma cases and growing patient inclination towards ambulatory day care procedures will serve to be positive impact rendering factors augmenting inhalation anesthesia industry growth. Accessibility of universal health insurance coverage to large population base with continuous improvements in healthcare facilities will further offer various growth opportunities. Moreover, benefits of inhalation anesthetics over injectable anesthetics will further stimulate inhalation anesthesia business growth.

Increasing burden of chronic diseases in developing and developed economies will primarily drive the market during the forecast period. Rising incidence of diseases including cardiac disease, neurovascular diseases and other chronic diseases will surge the demand for various surgical procedures. According to the Centers for Disease Control and Prevention, more than 730,000 Americans suffer a heart attack each year. Thus, growing demand for inhalation anesthetics during surgeries will favour business growth. However, several adverse effects of anesthetics may impede inhalation anesthesia industry growth over the analysis timeframe. 

Inhalation Anesthesia Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 1.3 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 5.4% 2025 Value Projection: 1.9 Billion (USD)
Pages: 170 Tables, Charts & Figures: 164
Geographies covered (25): U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, Netherlands, Switzerland, Japan, China, India, Australia, South Korea, Indonesia, Malaysia, Thailand, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE
Segments covered: Product, Application, End-use and Region
Companies covered (11): Abbott, Abbvie, Baxter International, Eisai, Fresenius Kabi, Halocarbon Products, Hikma Pharmaceuticals, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Mylan, Piramal
Growth Drivers:
  • Surge in number of emergency cases
  • Growing demand for surgical procedures worldwide
  • Rising geriatric population susceptible to chronic diseases
  • Advantages of inhalation anesthetics over injectable anesthetics
Pitfalls & Challenges:
  • Side effects associated with anesthetics

Get more details on this report - Request Free Sample PDF

Inhalation Anesthesia Market, By Product

Desflurane segment held over USD 255 million revenue in 2018 and is projected to grow significantly by 2025. Desflurane is a volatile, non-flammable and non-explosive agent extensively used in maintenance of general anesthesia. Advantages offered by desflurane such as low risk of nephrotoxicity and quick recovery as compared to sevoflurane will foster inhalation anesthesia market growth.

Isoflurane segment held around 5% revenue share in 2018 and is estimated to grow significantly by 2025. Segment growth is attributed to wide adoption of isoflurane owing to its cost-effectiveness in comparison with other anesthetics. Additionally, faster recovery as compared to halothane and minimal risk of fulminant hepatitis will boost inhalation anesthesia business growth during the forecast period.

Inhalation Anesthesia Industry, By Application

Induction inhalation anesthesia market segment accounted for more than USD 250 million in 2018. Induction of anesthesia necessitates higher concentration of drug as compared to the amount required for maintenance, thus increasing the demand for inhalation anesthetics. Such factors upsurge segmental growth over the coming years.

Maintenance segment held substantial revenue share in 2018 and is anticipated to witness more than 5% CAGR over the analysis timeframe. Segment growth is attributed to increasing demand for inhalation anesthetics due to airway safety airway and fast recovery as compared to injectable anesthetics.

Germany Inhalation Anesthesia Industry By Application

Get more details on this report - Request Free Sample PDF

Inhalation Anesthesia Market, By End-use

Hospitals segment held around 45% revenue share in 2018 and is projected to witness significant growth during the forecast period. The segment growth is mainly attributed to rising demand for various surgical procedures owing to favorable reimbursement policies for surgeries being performed in hospital settings.

Ambulatory surgical centers segment was valued over USD 500 million in 2018 due to growing population preference towards these centers. Several benefits offered by ASCs such as reduced risk of hospital acquired infections, quality treatment at affordable prices and shorter hospital stay will accelerate inhalation anesthesia business growth over the analysis period.

Inhalation Anesthesia Industry, By Region

North America inhalation anesthesia market size is estimated to witness more than 4.5% CAGR over the forecast timeline. Rising prevalence of chronic diseases as a result of unhealthy dietary habits and lifestyle changes will augment business growth. Increasing healthcare expenditure and strong foothold of prominent industry players in the region will spur the market size.

Asia Pacific market was valued around USD 270 million in 2018. Regional growth can be attributed to growing awareness regarding health issues and rising healthcare expenditure in the region. Presence of large patient pool opting for various surgical procedures will accelerate Asia Pacific inhalation anesthesia industry growth.

Asia Pacific Inhalation Anesthesia Market By Country

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Some of the notable industry players operating in inhalation anesthesia market share include Abbott, Baxter International, Halocarbon Products, Abbvie, Hikma Pharmaceuticals, Mylan, Eisai, Piramal, Lunan Pharmaceutical, Fresenius Kabi, and Jiangsu Hengrui Medicine. The business players implement various inorganic strategies including acquisitions, partnership as well as new product launches to capitalize on market opportunities. For instance, in October 2016, Piramal Enterprises acquired Janssen's injectable anesthesia and pain management products. This strategy enabled company to expand its critical care business portfolio and broaden existing customer base. Additionally, in May 2016, Julphar, a pharmaceutical manufacturer in the Middle East and Africa entered a partnership to market and distribute Sojourn (Sevoflurane), manufactured by Piramal, in Saudi Arabia. The partnership aimed at enhancing company’s business in the Middle East and Africa region and broadening existing customer pool.

 Industry Background

History of inhalation anesthesia can be traced back in 1846, when diethyl ether was first used by William Morton in the U.S. Ether subsisted as a viable agent for several years in the market as it prevented hypoxia and supported respiration & circulation. Later in 1847, James Simpson launched chloroform but had major problems including severe cardiovascular depression and sudden death. Further in 1929, cyclopropane was discovered for usage in various surgeries. However, increasing use of electronic equipment in anesthesia administration necessitated the production of a non-flammable agent. In 1956, halothane was developed by ICI for anesthetic practice. Additionally, introduction of enflurane and isoflurane in 1970 and 1981 respectively further increased the portfolio of inhalational anesthetics. Introduction of novel anesthetics to overcome the drawbacks of existing products will surge the market demand. Focus of business players on introduction of new anesthetic agents will boost the inhalation anesthesia industry growth.

Frequently Asked Questions (FAQ) :

The market size of inhalation anesthesia exceeded USD 1.3 billion in 2018.
The industry share of inhalation anesthesia will grow at 5.4% CAGR over 2019-2025.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jul 2019
  • Pages: 170
  • Tables: 156
  • Charts / Figures: 8
  • Companies covered: 11
  • Countries covered: 25

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X